Researchers move closer to a universal influenza vaccine

May 25, 2010

Researchers at Mount Sinai School of Medicine have developed a new influenza vaccine that brings science one step closer to a universal influenza vaccine that would eliminate the need for seasonal flu shots. The new findings can be found in the inaugural issue of mBio, the first online, open-access journal published by the American Society for Microbiology.

"Current influenza vaccines are effective against only a narrow range of influenza virus strains," said Peter Palese, Ph.D., Professor and Chair of the Department of Microbiology at Mount Sinai School of Medicine. "This new vaccine brings us closer to our ultimate goal of a vaccine that protects against multiple strains."

The current seasonal is strain-specific, targeting the globular head of the hemaglutinin (HA) molecule on the surface of the influenza virus. This globular head is highly variable and constantly changing from strain to strain. Each presents a different strain, making it necessary to adjust the vaccine each year.

In the new study, Dr. Palese and his colleagues developed a vaccine using HA without its globular head. Mice were injected with the vaccine and then following challenge were monitored for morbidity and mortality daily for 10 days. All of the mice vaccinated with the headless HA vaccine survived, while all unvaccinated mice died. Mount Sinai School of Medicine has submitted a for this vaccine approach.

"Our results suggest that the response induced by this vaccine is potent enough to warrant further development toward a universal influenza virus ," said Dr. Palese. "With further development and testing, we predict that a single immunization will in the future offer a sufficient defense against several influenza epidemics."

Explore further: Gene mutation discovered in blood disorder

Provided by The Mount Sinai Hospital

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

New steps toward a universal flu vaccine

May 19, 2010

Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their ...

Unusual flu vaccine is developed

Jun 14, 2006

U.S. scientists have used reverse genetics to develop an influenza virus with two key proteins on its surface derived from the H5N1 avian virus strain.

Universal flu vaccine holds promise

Apr 27, 2009

An influenza vaccine that protects against death and serious complications from different strains of flu is a little closer to reality, Saint Louis University vaccine researchers have found.

Bird flu vaccine protects people and pets

Oct 20, 2008

A single vaccine could be used to protect chickens, cats and humans against deadly flu pandemics, according to an article published in the November issue of the Journal of General Virology. The vaccine protects birds and ma ...

Recommended for you

Gene mutation discovered in blood disorder

13 minutes ago

An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells. Studying a family in which ...

Airway muscle-on-a-chip mimics asthma

2 hours ago

The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people ...

Lost protein could prevent hardening of the arteries

6 hours ago

(Medical Xpress)—Researchers have found that when the protein matrix metalloproteinase-14 (MMP-14) is reduced or lost, white blood cells, known as macrophages, become good and could prevent hardening of ...

User comments : 0